L. Z. ƏHMƏdova uşaq yaşlarinin nefrologiyasi
Yüklə 5,01 Kb. Pdf görüntüsü
|
245 239. Bussolati B, Peri G, Salvidio G,Verzola D, Mantovani A, Camussi G. The long pentraxin PTX3 is synthesized in IgA glomerulonephritis and activates mesangial cells. // J Immunol, 2003 Feb 1;170(3):1466-72. 240. Berger E.D.,Bader B.D., Ebert C et al. Reduction of proteinuria; combined effects of receptor biockade and low dose angiotensin- converting enzyme inhibition. // J. Hypertens.-2002. –Vol.20, №4.- P.739-743 241. Brenner B., Mackenzie H. Nephron mass as risk factor for progression of renal disease. // Kidney int.- 1997, 52 (Suppl. 63): 124- 7. 242. Boumpas D.T., Furie R., Manzi S., Illei G.G., Wallance D.J., Balow J.E., Vaishnaw A.A. short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. – // Arthritis Rheum. 2003 Mar; 48(3):719-27 243. Cameron J.S. Focal segmental glomerulosclerosis in adults .// Nephrol Dial Transplant, 2003. 18 [Suppl 6]/ - P/ vi45-vvi51. 244. D’Agati VD, Cohen DJ. Preimplantation renal biopsy: structure does predict function. // Transplantation. 2003 Feb 15;75 (3):264-6. Review. No abstract available. 245. Dixit M, Mansur A, Dixit N, Gilman J, Santarina L, Glicklich D. The role of ACE gene polymorphism in rapidity of progression of focal segmental glomerulosclerosis. //J Postgrad Med. 2002 Oct-Dec;48 (4):266-9; discussion 269. 246. Donadio JV, Grande JP. IgA nephropathy. // N Eng.l, J. Med. 2002, Sep 5;347(10):738-48. Review. No abstract available. 247. Duman VL. [Theraeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome]. //Ter Arkh. 2002;74 (6):39-41. Russian. 246 248. Drau V.J. Short-and long-term determinants of cardiovascular function and therapy: contributions of circulating and tissue renin-angiontensin systems // J.Cardiovasc. Pharmocol. 1989/-Voi.14. Supl.4- P.S.1-5 249. Filler G. Treatment of nephrotic syndrom in children and controlled triais. // Nephrol Dial Transplant, 2003. 18 [Suppl 6]/ - P/ vi75-vvi78. 250. Gasanov A.I., Akhmedova L.Z., Kulieva Z.M. Hemolitic-uremic syndrome in children. Fifth regional congress of pediatric societies of Turkish speaking coutries with international participation. // Bishkek, Kyrgystan, 1999, p. 4 251. Giri S, Mahajan SK, Sen R, Sharma A. Effects of angiotenism converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency. // J. Assoc Physicians India. 2002, Oct;50,1245-9. 252. Grech V, Vella C. Henoch-Schoenlein purpura with nephritis in two siblings following infectious mononucleosis. Ann Trop Paediatr., 2002 Sep;2(3),297- 8. No abstract avilable. 253. Haraguchi S, Tomiyoshi Y, Aoki S, Sakemi T. Nephrotic syndrome due to immunologically mediated hypocomplementic glomerulonephritis in a patient of Waldenstrom’s macroglobulinemia. //Nephron. –2002,Oct;92 (2),452-5. 254. Ignatova M., Prikhodina L., Golitsina E. et al.Association of thin basement membrane nephropathy and glomerulonephritis in children. Peditr. Nephrol. 2006; 21, 10: 357. 255. Haraguchi S, Tomiyoshi Y, Aoki S, Sakemi T. Nephrotic syndrome due to immunologically mediated hypocomplementic glomerulonephritis in a patient of Waldenstrom’s macroglobulinemia. //Nephron. –2002,Oct;92 (2),452-5. 256. Harald S., Mackenzie, Barry M. Brenner. Current strategies for Retarding Progression of Renal Disease. //Symposium Proceedings (part II) Update in Nephrology 1997: Hypertension, Lipids and Uremia Therapy. 247 257. Herlitz H., Harris R., Risler T. et all. The effect of an ACE inhibitor and a calcium antagonist on the progression of renal disease. //The Nephros Study. Nephrol. Dial. Transplant, 2001, vol. 16, p. 2158-2165. 258. Hikita T, Arai K, Inokami T, Kanda Y, Matsui K, Hidaka S, Uchida S, Nagase M. [A case of fulminant acute posrstreptococcal glomerulonephritis showingmesangiolysis and crescent formation preceded by erysipelas]. // Nippon Jinzo Gakkai Shi. 2002 Oct;44 (7), 558-63. Japanese. 259. Hirahashi J, Kuramochi S, Konishi K. et all. Glomerulonephritis with microtubular deposits associated with cryoglobulinemia and chronic active hepatitis. Pathol Int. 2002 Jul;5 2(7),483-7. 260. Herlitz H., Harris R., Risler T. et all. The effect of an ACE inhibitor and a calcium antagonist on the progression of renal disease. //The Nephros Study. Nephrol. Dial. Transplant, 2001, vol. 16, p. 2158-2165. 261. Hirahashi J, Kuramochi S, Konishi K. et all. Glomerulonephritis with microtubular deposits associated with cryoglobulinemia and chronic active hepatitis. Pathol Int. 2002 Jul;5 2(7),483-7. 262. Kadama H., Ohno G. Analytical epidemiology of urolitiasis. // Acta urol. Jap., 1989, vol 35, № 6, p. 935-937. 263. Kacprzyk F. Serum level and urinary excretion of RANTES in patients with primary glomerulonephritis]. // Pol Arch Med Wewn. 2002 Sep; 108 (3):837- 42. Polish. 264. Kanno T, Ito M, Kawase N, Taki Y, Yoshida H, Okuno H, Ogawa O. [A case of membranous glomerulonephritis in renal allograft]. // Hinyokika Kiyo. 2002 Jun;48 (6),379-82. Japanese. 265. Kansen K.J. Prevalence of ischemic nephropathy in the atherosclerotic population. //Amer. J. Kind. Dis., 1994, vol 24, № 3, p. 615-621. 266. Karakhanova M.S., Aliyeva S.G. An efficiency of Sorbening-sonography in the detection of the uronephrologic diseases in children of pre-school accompanying hematuria. //“Modern problem of population health care”, Baku, 1999, p. 106-108. 248 267. Kawashima M, Horita S, Nakayama H, Honda K, Uchida K, Nitta K, Yumura W, Nihei H. [Immunoelectron microscopic analysis of intraglomerular deposits in IgA-dominant immunotactoid glomerrulopathy] Rinsho Byori. 2002 Nov; 50 (11),1085-9. Japanese. 268. Kurokawa K, Abe K, Saruta T, Arakawa M, Kikkawa R,Ueda N, Onoyama K, Tomita K, Ogawa N. Antiproteinuric effect of candesartan cilexetil in patients with chronic glomerulonephritis. //J Renin Angiotensin Aldosterone Syst. 2002 Sep;3(3):167-75. 269. Lahbil D, Rais L, Hamdani M/ et all [Ocular impairment during type II membranoproliferative glomerulonephritis]. //J Fr Ophtalmol. 2002 Nov;25 (9),949-54. French. 270. Lai KN. Future directions in the treatment of IgA nephropathy. // Nephron. 2002 Oct;92 (2),263-70. 271. Laszlo F.A., Laszlo F.Ig, De Wied D. Phamocology and clinical perspectives of vasopressia antagonists// Pharmacol. Rev., 1991, vol 43, № 1, p. 73-108. 272. Lwis E.J., Hunsicker L.G.,Clarke W.R. et al. Renoprotective effekt of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 dia,etes// NEJM.-2001.-Voi.345, №12.-851-860. 273. Linossier MT, Palle S, Berthoux F. Different glycosylation porfile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thikness: normal versus thin. Am J Kidney Dis. 2003 Mar;41(3):558-64 274. Martin Govantes J. [Recurrence of focal glomerulosclerosis after renal translanttion.]. - // Nefrologia. 2002;22 (6), 507-9. Spanish. No abstract available. 275. Martinez Maldonado M. Role of hypertension in the progression of chronic renal disease.- // Dial. Transplant, 2001, 16 (Suppl 1), 63-66. 276. Martinez P, Burzako A, Lopez JI, Ortiz-Vigon R. [Membranoproliferative glomerulonephritis associated to Hepatitis C virus infection]. // Nefrologia. 2002;22 (6),582-3. Spanish. No abstract available. 249 277. Masuda M, Nakanishi K, Yoshizawa N, Iijima K, Yoshikawa N. Group A streptococcal antigen in the glomeruli of children with Henoch-Schonlein nephritis.- Am J Kidney Dis. 2003,Feb;41(2),366-70. 278. Masutani K, Mizumasa T, Iwanaga T, Shinozaki M, Yanagida T, Kashiwagi M, Fukuda K, Kanai H, Katafuchi R, Hirakata H. Superimposition of post- streptococcal acute glomerulonephritis on the course of IgA nephropathy: predominance of Th1 type immune response. // Clin Nephrol. 2002 Sep;58(3):224-30. 279. Matousovic K., Konecny K., Mestecky J., Tomana M., Novak J. [IgA nephropathy. Significance of immunoglobulin A glycosylation in pathogenesis and clinical presentation] Cas Lek Cesk. 2002, Nov 22; 141(23):729-34. Review. Czech. 280. Miki Y, Shimizu H, DanbaraA, Fujita Y, Ito Y, Matsuo S. [A case of mesangial proliferative glomerulonephritis with endothelial damage]. // Nippon Jinzo Gakkai Shi.- 2002, Oct,44(7),547-51. Japanese. 281. Miyata N, Kobayashi T, Matsukawa Y, Sawada S, Nishinarita S, Horie T. [Anti-neutrophil cytoppalsmatic autoantibody-associated rapid progressive glomerulonephritis complicated with both limited and diffuse scleroderma]. // Nihon Rinsho Meneki Gakkai Kaishi. 2002 Dec;25(6),743-9. Japanese. 282. Morales E, Martinez A, Sanchez-Ayuso J, Gutierrez E, Mateo S, Martinez MA, Herrero JC, Praga M. Spontaneous improvement of the renal function in a patient with HIV-associated focal glomerulosclerosis. // Am J Nephrol. 2002 Jul-Aug;22 (4),369-71. 283. Myllymaki J, Saha H, Mustonen J, Helin H, Pasternack A. IgM nephropathy: clinical picture and long-term prognosis. // Am J Kidney Dis. 2003 Feb;41(2):343-50. 284. Nagaba Y, Hiki Y, Aoyama T, Sano T, Matsuo T, Shimizu T, Tateno S, Sakamoto H, Kamata K, Shigematsu H, Higashihara M, Kobayashi Y. Effective antibiotic treatment of methicillin-resistant Staphylococcus aureus- associated glomerulonephritis. // Nephron., 2002, Oct;92 (2),297-303. 250 285. Nakahata T, SuzukiK, Tanaka H, Tateyama T, Waga S. [A case of ANCA- associated glomerulonephritis without extrarenal symptoms with disease flare after starting dialysis]. // Nippon Jinzo Gakkai Shi. 2002;44(5):483-6. Japanese. 286. Narsipur SS, Shanley PF. IgA nephropathy in a patient with chronic granulomatous disease. J Nephrol. 2002 Nov-Dec;15 (6),713-5. 287. Ohtaka A, Ootaka T, Sato H, Ito S. Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm? Nephrol Dial Transplant. 2002;17 Suppl 9,11-5. 288. Navar L.G., Harrison-Bernard L.M. Internal angiotensin II augmentation in angiotensin II dependent hypertension. // Hypertens. Res.-2000.-Vol23,№4. – P.291-301. 289. Oliveira DB. The immunopathogenesis of membranuos nephropathy.- //Minerva Med. 2002 Oct;93 (5),323-8. Review. 290. Olowu WA. Systemic complications of acute glomerulonephritis in Nigerian children. -Niger Postgrad Med J. 2002 ,Jun;9 (2),83-7. 291. Palamarchuk MI, Kukhetevich AV, Sokolova ED. [Clinical varieties of chronic glomerulonephritis and psychic characteristics of patients]. // Ter Arkh. 2002;74 (6).ю49-52. Russian. 292. Pape L., Offner G., Ehrich J. et al. A single center clinical experience in intensive care management of 104 pediatric renal transplantation between 1994 and 2002. Pediatric Transplantation. 2004; 8: 39–43. 293. Parildar Z, Uslu R, Tanyalcin T, Doganavsargil E, Kutay F. The urinary excretion of glycosaminoglycans and herapan sulphate in lupus nephritis. // Clin Rheumatol. 2002,Aug;21(4),284-8. 294. Perez-Calvo J, Lasierra P, Moros M, Inigo P. Role of ribavirin in membranoproliferative glomerulonephritis associated with hepatitis C virus infection refractory to alpha-interferon. // Nephron. 2002, Oct;92(2),459-62. 251 295. Pozzi C, Del Vecchio L, Locatelli F. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].- G Ital Nefrol. 2002 Sep-Oct;19 (5),523-8. Review. Italian. 296. Praga M.Slowing the progression of renal failure. //Kidney Int.-2002.- Vol61,№5-P.18/ 297. Ruiz P, Soares MF. Acute postinfecious glomerulonephritis: an immune response gone bad? Hum Pathol. 2003 Jan;34 (1),1-2. review. No abstract available. 298. Ritz E. Dosing angiotensin II blokers-beyond blood pressure. // Nephrol. Dial. Transplant. 1999.-Vol.14.-P/2568-2570. 299. Rogov VA, Shilov EM, Sidorova IS, Rogova EF, Makarov IO, Zozulia OV. [Renal and uterine hemodynamics in pregnancy with chronic glomerulonephritis of the hypertonic type]. // Ter Arkh. 2002;74 (10),52-5. Russian. 300. Ruiz P, Soares MF. Acute postinfecious glomerulonephritis: an immune response gone bad? Hum Pathol. 2003 Jan;34 (1),1-2. review. No abstract available. 301. Rumizzi G., Ruggenenti P., Benigui A. Understanding the nature of renal disease progression. // Kidney Int., 1997, vol. 51, p. 2-15. 302. Rybin PN, Potekhin NP, Maksimov VA, Varshavskii VA, Proskurneva EP. [Viruses and glomerulonephritis].- // Voen Med Zh. 2002 Oct;323 (10),52-7. Russian. No abstract available. 303. Rodrigues- Hurbe. Qlomerulonephritis assotiated with infection. F: poststrepococcal glomerulonephritis // in: Massri S/G/ Glossal, eds. Textbook of Nephroloji. // Willians, Baltimore, 1995, p.698-703. 304. Sakarcan A, Neuberg RW, McRedmond KP, Islek I. Membranoproliferative glomerulonephritis develops in a child with autologous stem cell transplant. - Am J Kidney Dis. 2002, Dec;40 (6),E19. 305. Santos NM, Ault BH, Gharavi AG, Kritchevsky SB, Quasney MW, Jackson EC, Fisher KA, Woodford SY, Mitchell BL, Gaber LW, Arheart KL, Wyatt 252 RJ. Angiotenism-converting enzyme genotype and outcome in pediatric IgA nephropathy. // Pediatr Nephrol. 2002 Jul;17 (7),469-502. 306. Schmidt U, Franke J, Thomae U, Mann J.- [Glomerulonephritis]. //Internist (Berl). 2002 Jun;43 (6),749-56. German. No abstract available. 307. Shilov EM, Tareeva IE, Ivanov AA, Troepol’skaia OV, Krasnova TN, Varshavskii VA, Proskurneva EP, Ivanova LV, Hudova Iiu, Miroshnichenko NG. [The cource and prognosis of mesangioproliferative glomerulonephritis]. //Ter Arkh. 2002;74 (6),11-8. Russian. 308. Singh S, Devidayal, Kuma L, Josni K, Minz RW, Datta U. Severe Henoch- Schonlein nephritis: resolution with azathioprine and steroids. // Rheumatol Int. 2002 Aug;22 (4),133-7. 309. Sraer I.D. Перспективы и задачи нефрологического отделения на рубеже 2000 г. Российский вестник перинатологии и педиатрии, 2000, № 6, с. 45. 310. Strutz F., Muller C.A., Muller G.A. //Oxford Textbook of Clinical Nephrology. Oxford, 1998, vol. 2, p. 1113-1129. 311. Suehiro T, Masutani K, Yokoyama M, Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Katafuchi Y, Hirakata H. Diffuse proliferative glomerulonephritis after bone marrow transplantation. // Cliп Nephrol. 2002 Sep;58 (3),231-7. Review. 312. Takaki A, Nakatsuka A, SatouC, Iwata Y, Ikeda H, Fukushima M. [A case of focal segmental glomerulosclerosis(FSGS) complicated with chronic hepatitis B and treted with steroid and LDL apheresis]. // Nippon Jinzo Gakkai Shi. 2002, Dec;44 (8),806-12. Japanese. 313. Tanaka H, Waga S, Suzuki K, Nakahata T, Kawashi H, Shimizu F, Ito E. Rapidly progressive, pauci-immune diffuse crescentic glomerulonephritis in an infant. Pediatr Nephrol., 2002, Sep;17 (9),730-2. 314. Tenbrock K., Muller-Berghause J., Fuchshuber A., Michalki D., Querfeld U. Применение левомизола при гормоночувствительном и 253 гормонорезистентном нефротическом синдроме. – //Российский вестник перинатологии и педиатрии, 2000, № 6, с. 54. 315. Tomino Y. [Committee of IgA Nephropathy – the Special Study Group of Progressive Glomerular Disease, the Ministry of Health, Labor and Welfare of Japan]. // Nippon Jinzo Gakkai Shi. 2002 Oct;44(7):487-93. Japanese. No abstract available. 316. Jacobson H., Striker G. Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. //Amer. J. Kidney Diseases, 1995, 25, 103-105. 317. Vijayakumar M. Acute and crescentic glomerulonephritis. //Indian J Pediatr., 2002, Dec;69 (12),1071-5. Review 318. Vikse BE, Bostad L, Aasarod K, Lysebo DE, Iversen BM. Prognostic factors in mesangioproliferative glomerulonephritis. // Nephrol Dial Transplant. 2002 Sep;17(9),1603-13. 319. Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D. Histologic and immunohostologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis., 2003, mar;41(3),539-49. 320. Voznesenskaia TS, Sergeeva TV. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis]. // Ter Arkh. 2002;74(6):31-3. Russian. 321. Williams D. Pathogenesis of idiopathic Ig A nephropathy. //Pediatr. Nephrol., 1993, vol. 7, № 3 p., 303-311. 322. Yoon HJ, Shin JH, Yang SH, Chae DW, Kim H, Lee DS, Kim HL, Kim S, Lee JS, Kim YS. Association of the CD14 gene – 159C polymorphism with progression of IgA nephropathy. // J. Med Genet., 2003, Feb;40 (2),104-8. Yüklə 5,01 Kb. Dostları ilə paylaş:
|